Reviva Pharmaceuticals Holdings, Inc. (RVPH) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$0.53
—
Mkt Cap $6.85M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$1.08 | -$0.72 | +33.33% |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.11 | -$0.06 | +45.45% |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.15 | -$0.12 | +20.00% |
| Q2 2025 May 15, 2025 | — | — | — | -$0.21 | -$0.13 | +38.10% |
| Q1 2025 Mar 31, 2025 | — | — | — | -$0.22 | -$0.15 | +31.82% |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.23 | -$0.25 | -8.70% |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.28 | -$0.26 | +7.14% |
| Q2 2024 May 14, 2024 | — | — | — | -$0.28 | -$0.25 | +10.71% |
| Q2 2024 Apr 15, 2024 | — | — | — | -$0.35 | -$0.35 | +0.00% |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.35 | -$0.44 | -25.71% |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.29 | -$0.55 | -89.66% |
| Q2 2023 May 15, 2023 | — | — | — | -$0.36 | -$0.30 | +16.67% |
| Q1 2023 Mar 30, 2023 | — | — | — | -$0.23 | -$0.38 | -65.22% |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.30 | -$0.18 | +40.00% |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.31 | -$0.29 | +6.45% |
| Q2 2022 May 16, 2022 | — | — | — | -$0.28 | -$0.40 | -42.86% |
| Q1 2022 Mar 15, 2022 | — | — | — | -$0.24 | -$0.24 | +0.00% |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.25 | -$0.12 | +52.00% |
| Q3 2021 Aug 16, 2021 | — | — | — | -$0.24 | -$0.12 | +50.00% |
| Q2 2021 May 17, 2021 | — | — | — | — | -$0.10 | — |
| Q1 2021 Mar 22, 2021 | — | — | — | -$0.06 | -$3.30 | -5402.42% |
| Q3 2020 Sep 14, 2020 | — | — | — | — | -$4.75 | — |
| Q3 2020 Jul 7, 2020 | — | — | — | — | -$6.15 | — |
| Q2 2020 May 2, 2020 | — | — | — | — | -$1.95 | — |
| Q1 2020 Jan 10, 2020 | — | — | — | — | $1.05 | — |
| Q4 2019 Oct 8, 2019 | — | — | — | — | $2.11 | — |
| Q3 2019 Jul 3, 2019 | — | — | — | — | $2.60 | — |
| Q2 2019 May 22, 2019 | — | — | — | — | -$0.76 | — |
| Q1 2019 Jan 9, 2019 | — | — | — | — | $2.03 | — |
| Q4 2018 Oct 11, 2018 | — | — | — | — | $0.24 | — |
| Q2 2018 May 31, 2018 | — | — | — | — | -$0.19 | — |